Explore 3 Stock Ideas & Industry Insights Download Free Report

8082-737-676
Shopping Cart 0
countryflagUK
Login

Arjo AB (publ)

Healthcare US ARRJF

2.965USD
0.95(47.15%)

Last update at 2026-04-22T20:00:00Z

Day Range

3.273.51
LowHigh

52 Week Range

2.124.59
LowHigh

Fundamentals

  • Previous Close 2.02
  • Market Cap807.58M
  • Volume325
  • P/E Ratio22.81
  • Dividend Yield-%
  • EBITDA1471.00M
  • Revenue TTM11175.00M
  • Revenue Per Share TTM41.03
  • Gross Profit TTM 4835.00M
  • Diluted EPS TTM0.13

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax 467.00M 684.00M 640.00M 597.00M 989.00M
Minority interest - - - - -
Net income 334.00M 498.00M 480.00M 449.00M 742.00M
Selling general administrative 1463.00M 1511.00M 1462.00M 1329.00M 1222.00M
Selling and marketing expenses 2211.00M 2236.00M 2163.00M 1969.00M 1753.00M
Gross profit 4685.00M 4906.00M 4736.00M 4211.00M 4209.00M
Reconciled depreciation 1136.00M 1062.00M 1146.00M 1077.00M 956.00M
Ebit 831.00M 935.00M 903.00M 622.00M 1076.00M
Ebitda 1967.00M 2013.00M 1961.00M 1699.00M 2032.00M
Depreciation and amortization 1136.00M 1078.00M 1058.00M 1077.00M 956.00M
Non operating income net other - - - - -
Operating income 831.00M 893.00M 884.00M 691.00M 1077.00M
Other operating expenses 10169.00M 10399.00M 10096.00M 9205.00M 7946.00M
Interest expense 210.00M 251.00M 263.00M 115.00M 87.00M
Tax provision 132.00M 187.00M 129.00M 149.00M 247.00M
Interest income 30.00M 30.00M 28.00M 16.00M 4.00M
Net interest income -209.00000M -209.00000M -231.00000M -119.00000M -94.00000M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 132.00M 187.00M 160.00M 149.00M 247.00M
Total revenue 11000.00M 11292.00M 10980.00M 9979.00M 9070.00M
Total operating expenses 3436.36M 4013.00M 3852.00M 3437.00M 3085.00M
Cost of revenue 6315.00M 6386.00M 6244.00M 5768.00M 4861.00M
Total other income expense net -364.00000M -209.00000M -244.00000M -94.00000M -88.00000M
Discontinued operations - - - - -
Net income from continuing ops 335.00M 497.00M 388.00M 447.00M 742.00M
Net income applicable to common shares - - - 447.00M 742.00M
Preferred stock and other adjustments - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 14977.00M 16276.00M 15444.00M 16167.00M 14612.00M
Intangible assets 1705.00M 1756.00M 1040.00M 1718.00M 1694.00M
Earning assets - - - - -
Other current assets 119.00M 445.00M 2193.00M - 32.00M
Total liab 7520.00M 7938.00M 7862.00M 8543.00M 7727.00M
Total stockholder equity 7457.00M 8338.00M 7582.00M 7624.00M 6885.00M
Deferred long term liab - - - - 468.00M
Other current liab 1393.00M 1586.00M 1396.00M 1354.00M 1372.00M
Common stock 91.00M 91.00M 91.00M 91.00M 91.00M
Capital stock 91.00M 91.00M 91.00M 91.00M 91.00M
Retained earnings 6534.00M 6440.00M 6176.00M 6138.00M 6028.00M
Other liab - - - 1614.00M 257.00M
Good will 5510.00M 5895.00M 5637.00M 5673.00M 5405.00M
Other assets -1.00000M 3.00M 2.00M - 1.00M
Cash 836.00M 892.00M 923.00M 949.00M 757.00M
Cash and equivalents - - - - -
Total current liabilities 3759.00M 4597.00M 4396.00M 4622.00M 6491.00M
Current deferred revenue - - 1257.00M 1142.00M 1156.00M
Net debt 4517.00M 4526.00M 4563.00M 5364.00M 4696.00M
Short term debt 1858.00M 2404.00M 2299.00M 2681.00M 4505.00M
Short long term debt 1450.00M 1976.00M 1934.00M 2322.00M 4177.00M
Short long term debt total 5353.00M 5418.00M 5486.00M 6313.00M 5453.00M
Other stockholder equity 832.00M 1807.00M 1315.00M 1395.00M 766.00M
Property plant equipment - - - 2909.00M 2555.00M
Total current assets 4324.00M 4851.00M 4417.00M 5030.00M 4174.00M
Long term investments - - - - -
Net tangible assets - - - 233.00M 254.00M
Short term investments - - -76.00000M - -
Net receivables 2192.00M 2126.00M 2000.00M 1708.00M 1913.00M
Long term debt 2637.00M 2163.00M 2391.00M 2823.00M 118.00M
Inventory 1177.00M 1388.00M 1301.00M 1674.00M 1369.00M
Accounts payable 508.00M 607.00M 612.00M 587.00M 614.00M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - 1807.00M 1315.00M - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 1.85M 728.00M 1300.00M 523.00M 526.00M
Deferred long term asset charges - - - - -
Non current assets total 10654.00M 11422.00M 11025.00M 11137.00M 10437.00M
Capital lease obligations 1266.00M 1279.00M 1161.00M 1168.00M 1158.00M
Long term debt total - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments -678.00000M -637.00000M -789.00000M -902.00000M -695.00000M
Change to liabilities - - - 0.00000M 0.00000M
Total cashflows from investing activities -705.00000M -635.00000M - -902.00000M -695.00000M
Net borrowings 49.00M -335.00000M - 204.00M -1196.00000M
Total cash from financing activities -730.00000M -907.00000M -1427.00000M 136.00M -1277.00000M
Change to operating activities - - - -270.00000M 21.00M
Net income 675.00M 884.00M 480.00M 691.00M 1077.00M
Change in cash 93.80M -31.00000M -26.00000M 192.00M -215.00000M
Begin period cash flow 892.00M 923.00M 949.00M 757.00M 972.00M
End period cash flow 836.00M 892.00M 923.00M 949.00M 757.00M
Total cash from operating activities 1435.00M 1516.00M 2061.00M 915.00M 1734.00M
Issuance of capital stock - - - - -
Depreciation 1136.00M 1062.00M 1062.00M 1077.00M 956.00M
Other cashflows from investing activities 25.23M -580.00000M - -1.00000M -1.00000M
Dividends paid 259.00M 245.00M 232.00M 313.00M 232.00M
Change to inventory 77.00M 192.00M 192.00M -165.00000M -232.00000M
Change to account receivables 13.00M 130.00M 130.00M -76.00000M 135.00M
Sale purchase of stock - - - - -
Other cashflows from financing activities -520.00000M -327.00000M -24925.00000M 24196.00M 9763.00M
Change to netincome - - - -97.00000M 112.00M
Capital expenditures 676.30M 393.00M 604.00M 900.00M 760.00M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 20.00M 525.00M 525.00M -511.00000M -76.00000M
Stock based compensation - - - - -
Other non cash items -396.00000M -955.00000M -6.00000M -342.00000M -223.00000M
Free cash flow 755.10M 1123.00M 1457.00M 15.00M 974.00M

Peer Comparison

Sector: Healthcare Industry: Medical Distribution

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
ARRJF
Arjo AB (publ)		 0.95 47.15% 2.96 22.81 16.29 673.14 0.99 1.08 6.70
COR
Cencora Inc.		 -1.2 0.45% 263.64 37.46 17.70 0.19 31.84 0.20 17.10
MCK
McKesson Corporation		 2.75 0.37% 739.53 17.95 14.53 0.20 5.04 0.22 12.17
CAH
Cardinal Health Inc		 0.97 0.50% 195.85 29.48 17.92 0.20 16.07 0.22 15.67
HSIC
Henry Schein Inc		 -0.3 0.39% 75.74 24.12 14.04 0.74 2.50 0.95 13.33

Reports Covered

Stock Research & News

View All

Profile

Arjo AB (publ) develops and sells medical devices and solutions for patients for clinical and financial outcomes for healthcare in Europe, Asia, Latin America, Africa, and the Pacific. It offers products and solutions for patient handling, hygiene, disinfection, medical beds, pressure injury prevention, diagnostics, hygiene, prevention of pressure injuries and blood clots, and leg ulcer treatment and prevention, as well as for obstetric and cardiac diagnostics. The company also provides dementia care, bariatric room solutions, prone positioning, early mobility, architects and planners, and rehabilitation services, as well as equipment repair and maintenance, and equipment rental and financing solutions. It serves private and public institutions that provide acute and long-term care. Arjo AB (publ) was founded in 1957 and is headquartered in Malmö, Sweden.

Arjo AB (publ)

Hans Michelsensgatan 10, Malmö, Sweden, 201 20

Key Executives

Name Title Year Born
Mr. Joacim Lindoff CEO, Pres & Director 1973
Mr. Daniel Fäldt Chief Financial Officer 1976
Jonas Cederhage Exec. VP of Product Devel., Supply Chain & Operations 1971
Ms. Ingrid Carlsson Exec. VP of Legal & Bus. Compliance and Board Sec. 1976
Ms. Kornelia Rasmussen Exec. VP of Communication & PR 1977
Mr. Paul Lyon Pres Global Sales & Service 1962
Tobias Kramer Exec. VP of Global Marketing NA
Ms. Marion Gullstrand Exec. VP of HR & Sustainability 1957
Ms. Katarzyna Bobrow Exec. VP of Quality & Regulatory Compliance 1980
Mr. Christian Stentoft Exec. VP & Chief Strategy Officer 1984

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions